USPTO serial 77027863
GEOCLOCK
Reviewed by CopyMark Law Group
Reg. 4133487Status 710
- Filing date
- Status date
- Registration date
- May 1, 2012
- Examiner
- WELLS, KELLEY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GEOCLOCK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CH-4132 Muttenz, CH
CH-4132 Muttenz, CH
CH-4132 Muttenz, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter J. Riebling
Peter J. Riebling Riebling IP, PLLC1717 Pennsylvania Avenue NWSuite 1025Washington, DC 20006-3951Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals having a time release effect used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; pharmaceutical and veterinary preparations used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; preparations for medical, surgical and biological purposes for the treatment of diseases of the nervous system, sleep disorders and arthritis; dietetic foods containing pharmaceutically active substances adapted for medical or veterinary use; beverages, solutions and foods for the purpose of providing a time release effect, for use in the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; chronotherapy-focused press coated tablets, analgesics; bacterial preparations for medical and veterinary purposes; chemical reagents for medical and veterinary purposes; diagnostic reagents for medical use; chemical reagents and chemical preparations for pharmaceutical use in the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; medicinal and veterinary oils used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; diagnostic preparations for medical and veterinary purposes; medicines and medicinal preparations used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; tablets for the release of colonic drug delivery; drugs for the treatment of sleep disorders; medical and veterinary preparations for slimming purposes; ointments, creams and powders for medical and veterinary purposes used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; capsules, suppositories, tablets and pills for pharmaceutical, medical and veterinary purposes used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; pre-filled instruments and apparatus for the administration of time release therapy and prophylaxis preparations and substances, namely, vials, inhalers, syringes, needles and injectors used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; medical, veterinary and surgical apparatus, instruments and devices, namely, pre-filled vials, syringes and injectors for medical purposes for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology | SECTION 8 - CANCELLED | — |
| 010 | Inhalers for medical purposes, and medical and veterinary syringes and needles; catheters; syringes and injectors for medical purposes | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 7, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 1, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 15, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 10, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 4, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 4, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 1, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 27, 2012 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Mar 23, 2012 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Mar 23, 2012 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Sep 29, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Sep 28, 2011 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 22, 2011 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 22, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 30, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Mar 29, 2011 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 28, 2011 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 17, 2011 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 17, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 25, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Sep 23, 2010 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 23, 2010 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 23, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 23, 2010 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 29, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 9, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 25, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 25, 2009 | ALIE | ASSIGNED TO LIE | — |
| Nov 17, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 10, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 10, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 10, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2009 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2009 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 24, 2009 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 13, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 9, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 9, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2009 | ALIE | ASSIGNED TO LIE | — |
| Apr 9, 2009 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 9, 2008 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 8, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 20, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2008 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 22, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 21, 2008 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Mar 21, 2008 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 21, 2007 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Sep 21, 2007 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 6, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 6, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 6, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 28, 2006 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Oct 27, 2006 | NWAP | NEW APPLICATION ENTERED | — |